ArticleFrontiers in immunology2025

Efficacy and safety of immunotherapy rechallenge in second-line treatment after failure of first-line immune checkpoint inhibitors combined with chemotherapy in advanced gastric cancer: a retrospective study.

Fei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.